RABIES AND KEDRAB PRESS RELEASES

June 2, 2021

Kedrion and Kamada Announce FDA Approval of KEDRAB® Label Update, Confirming Safety and Effectiveness in Children

February 10, 2021

Rabies Treatment Demonstrated as Safe and Effective for Use in Children in First Pediatric Trial

August 19, 2020

Kamada and Kedrion Biopharma Announce Results of First and Only U.S. Post-Marketing Pediatric Trial of a Human Rabies Immune Globulin (HRIG); The Study Met Its Primary Objective